#ESCCongress – [Abstract Only] Randomized Trial Supports Oral Anticoagulant Monotherapy for Patients with Atrial Fibrillation and Stable Coronary Disease
3 Sep, 2019 | 01:26h | UTCAntithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD – TCTMD (free) AND Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease – AFIRE – American College of Cardiology (free)
Related: Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation – American Journal of Cardiology (link to abstract – $ for full-text)